Nobel laureate has high hopes for donor iPS cells

Latest trial could pave way for cheaper, faster treatment, says Shinya Yamanaka

20170405_yamanaka

Shinya Yamanaka hopes a recent transplant involving donor-derived iPS cells will lead to the widespread use of regenerative treatments.

KYOTO A team of Japanese doctors recently performed a landmark surgery involving the use of donated induced pluripotent stem, or iPS cells, to treat macular degeneration, an intractable eye disease.

The operation, which used cells gathered and prepared ahead of time, was performed at Kobe City Medical Center General Hospital as part of a joint project also involving researchers from Riken and Kyoto University's Center for iPS Cell Research and Application, or CiRA.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.